Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3059766 | 0.89 | — | — | |
| SCHEMBL7209074 | 0.69 | POLB (0.35) | POLB | |
| SCHEMBL913291 | 0.67 | POLB (0.34) | POLB | |
| SCHEMBL7431766 | 0.65 | POLB (0.31) | POLBATM | |
| SCHEMBL3132415 | 0.64 | CA12 (0.34) | POLBATM | |
| SCHEMBL9533869 | 0.64 | GLA (0.35) | POLB | |
| SCHEMBL11710143 | 0.63 | POLB (0.32) | POLB | |
| SCHEMBL43721 | 0.63 | POLB (0.32) | POLB | |
| SCHEMBL9285475 | 0.63 | POLB (0.32) | POLB | |
| SCHEMBL2754568 | 0.62 | LMNA (0.33) | POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100080770-A1 | Hepatitis C Virus Inhibitors | BRISTOL-MYERS SQUIBB COMPANY | 2010-04-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100080770-A1 | Hepatitis C Virus Inhibitors | HAVCR2, HCCS, PYGL | POLB 1458/4885ATM 4431/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.